{"id":71077,"date":"2021-01-07T13:20:26","date_gmt":"2021-01-07T21:20:26","guid":{"rendered":"https:\/\/chemicalsafety.com\/la-aprobacion-de-emergencia-de-ee-uu-amplia-el-uso-del-medicamento-covid-19-remdesivir-de-gilead\/"},"modified":"2025-10-01T01:09:13","modified_gmt":"2025-10-01T08:09:13","slug":"la-aprobacion-de-emergencia-de-ee-uu-amplia-el-uso-del-medicamento-covid-19-remdesivir-de-gilead","status":"publish","type":"post","link":"https:\/\/chemicalsafety.com\/es\/la-aprobacion-de-emergencia-de-ee-uu-amplia-el-uso-del-medicamento-covid-19-remdesivir-de-gilead\/","title":{"rendered":"La aprobaci\u00f3n de emergencia de EE. UU. Ampl\u00eda el uso del medicamento COVID-19 remdesivir de Gilead"},"content":{"rendered":"<p>Durante estos tiempos dif\u00edciles, las buenas noticias siempre son bienvenidas y deben compartirse. Nos sentimos honrados y orgullosos de anunciar que <a href=\"https:\/\/www.gilead.com\/\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.gilead.com\/&amp;source=gmail&amp;ust=1589368664833000&amp;usg=AFQjCNH0Z4W0TcTIcz8cyLVfBiMNo8850g\">Gilead Sciences<\/a>, uno de los clientes m\u00e1s antiguos e importantes de Chemical Safety Software, ha recibido la aprobaci\u00f3n de la Administraci\u00f3n de Drogas y Alimentos de los EE. UU. <a href=\"https:\/\/www.fda.gov\/home\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/home&amp;source=gmail&amp;ust=1589368664833000&amp;usg=AFQjCNFwe9aHO0Hf_UftX3R_lzezq9y5YA\">(FDA)<\/a> para su tratamiento experimental Covid-19 llamado Remdesivir.<\/p>\n<p>Durante una reuni\u00f3n en la Oficina Oval de la Casa Blanca con el presidente Donald Trump, el presidente ejecutivo de Gilead, Daniel O&#8217;Day, calific\u00f3 la medida como un primer paso importante y dijo que la compa\u00f1\u00eda estaba donando 1,5 millones de viales del medicamento para ayudar a los pacientes. Se espera que la donaci\u00f3n sea suficiente para al menos 140.000 pacientes, dependiendo de la cantidad de d\u00edas que necesiten ser tratados.<\/p>\n<p>Gilead (<a href=\"https:\/\/www.google.com\/search?q=NASDQ+GILD&amp;oq=NASDQ+GILD&amp;aqs=chrome..69i57j0l7.1136j0j7&amp;sourceid=chrome&amp;ie=UTF-8\">NASDQ GILD<\/a>) said the drug, which is given by intravenous infusion, had helped improve outcomes for patients with COVID-19, the respiratory disease caused by the novel coronavirus, and provided data suggesting it worked better when given earlier in the course of infection.<\/p>\n<p>Aplaudimos los esfuerzos de Gilead y nos unimos a todos nosotros para escuchar m\u00e1s buenas noticias sobre esta nueva opci\u00f3n de tratamiento.<\/p>\n<p>Fuentes:<\/p>\n<p><a href=\"https:\/\/www.barrons.com\/articles\/coronavirus-news-updates-51588339547\" target=\"_blank\" rel=\"noopener\">La FDA otorga autorizaci\u00f3n de emergencia para el medicamento Covid-19 de Gilead<\/a><br \/>\n<a href=\"https:\/\/www.reuters.com\/article\/health-coronavirus-usa-fda\/us-emergency-approval-broadens-use-of-gileads-covid-19-drug-remdesivir-idUSL1N2CM0ZH\" target=\"_blank\" rel=\"noopener\">La aprobaci\u00f3n de emergencia de EE. UU. Ampl\u00eda el uso del medicamento COVID-19 remdesivir de Gilead<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Durante estos tiempos dif\u00edciles, las buenas noticias siempre son bienvenidas y deben compartirse. Nos sentimos honrados y orgullosos de anunciar que Gilead Sciences, uno de los clientes m\u00e1s antiguos e importantes de Chemical Safety Software, ha recibido la aprobaci\u00f3n de la Administraci\u00f3n de Drogas y Alimentos de los EE. UU. (FDA) para su tratamiento experimental [&hellip;]<\/p>\n","protected":false},"author":3590,"featured_media":89595,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_eb_attr":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[197],"tags":[],"class_list":["post-71077","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categorizar"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.0 (Yoast SEO v26.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>La aprobaci\u00f3n de emergencia de EE. UU. Ampl\u00eda el uso del medicamento COVID-19 remdesivir de Gilead<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/chemicalsafety.com\/es\/la-aprobacion-de-emergencia-de-ee-uu-amplia-el-uso-del-medicamento-covid-19-remdesivir-de-gilead\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La aprobaci\u00f3n de emergencia de EE. UU. Ampl\u00eda el uso del medicamento COVID-19 remdesivir de Gilead\" \/>\n<meta property=\"og:description\" content=\"Durante estos tiempos dif\u00edciles, las buenas noticias siempre son bienvenidas y deben compartirse. Nos sentimos honrados y orgullosos de anunciar que Gilead Sciences, uno de los clientes m\u00e1s antiguos e importantes de Chemical Safety Software, ha recibido la aprobaci\u00f3n de la Administraci\u00f3n de Drogas y Alimentos de los EE. UU. (FDA) para su tratamiento experimental [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/chemicalsafety.com\/es\/la-aprobacion-de-emergencia-de-ee-uu-amplia-el-uso-del-medicamento-covid-19-remdesivir-de-gilead\/\" \/>\n<meta property=\"og:site_name\" content=\"ChemicalSafety\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Chemical-Safety-Software-1391503304442241\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-07T21:20:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-01T08:09:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/chemicalsafety.com\/wp-content\/uploads\/2020\/05\/gileads-covid-19-drug-remdesivir-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"750\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Chemical Safety Software\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@chemsafeems\" \/>\n<meta name=\"twitter:site\" content=\"@chemsafeems\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Chemical Safety Software\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/chemicalsafety.com\/es\/la-aprobacion-de-emergencia-de-ee-uu-amplia-el-uso-del-medicamento-covid-19-remdesivir-de-gilead\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/chemicalsafety.com\/es\/la-aprobacion-de-emergencia-de-ee-uu-amplia-el-uso-del-medicamento-covid-19-remdesivir-de-gilead\/\"},\"author\":{\"name\":\"Chemical Safety Software\",\"@id\":\"https:\/\/chemicalsafety.com\/es\/#\/schema\/person\/9a6af7129d32d51cd09d6bbfbcb03336\"},\"headline\":\"La aprobaci\u00f3n de emergencia de EE. UU. Ampl\u00eda el uso del medicamento COVID-19 remdesivir de Gilead\",\"datePublished\":\"2021-01-07T21:20:26+00:00\",\"dateModified\":\"2025-10-01T08:09:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/chemicalsafety.com\/es\/la-aprobacion-de-emergencia-de-ee-uu-amplia-el-uso-del-medicamento-covid-19-remdesivir-de-gilead\/\"},\"wordCount\":252,\"publisher\":{\"@id\":\"https:\/\/chemicalsafety.com\/es\/#organization\"},\"image\":{\"@id\":\"https:\/\/chemicalsafety.com\/es\/la-aprobacion-de-emergencia-de-ee-uu-amplia-el-uso-del-medicamento-covid-19-remdesivir-de-gilead\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/chemicalsafety.com\/wp-content\/uploads\/2020\/05\/gileads-covid-19-drug-remdesivir-1.jpg\",\"articleSection\":[\"Sin categorizar\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/chemicalsafety.com\/es\/la-aprobacion-de-emergencia-de-ee-uu-amplia-el-uso-del-medicamento-covid-19-remdesivir-de-gilead\/\",\"url\":\"https:\/\/chemicalsafety.com\/es\/la-aprobacion-de-emergencia-de-ee-uu-amplia-el-uso-del-medicamento-covid-19-remdesivir-de-gilead\/\",\"name\":\"La aprobaci\u00f3n de emergencia de EE. UU. Ampl\u00eda el uso del medicamento COVID-19 remdesivir de Gilead\",\"isPartOf\":{\"@id\":\"https:\/\/chemicalsafety.com\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/chemicalsafety.com\/es\/la-aprobacion-de-emergencia-de-ee-uu-amplia-el-uso-del-medicamento-covid-19-remdesivir-de-gilead\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/chemicalsafety.com\/es\/la-aprobacion-de-emergencia-de-ee-uu-amplia-el-uso-del-medicamento-covid-19-remdesivir-de-gilead\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/chemicalsafety.com\/wp-content\/uploads\/2020\/05\/gileads-covid-19-drug-remdesivir-1.jpg\",\"datePublished\":\"2021-01-07T21:20:26+00:00\",\"dateModified\":\"2025-10-01T08:09:13+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/chemicalsafety.com\/es\/la-aprobacion-de-emergencia-de-ee-uu-amplia-el-uso-del-medicamento-covid-19-remdesivir-de-gilead\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/chemicalsafety.com\/es\/la-aprobacion-de-emergencia-de-ee-uu-amplia-el-uso-del-medicamento-covid-19-remdesivir-de-gilead\/#primaryimage\",\"url\":\"https:\/\/chemicalsafety.com\/wp-content\/uploads\/2020\/05\/gileads-covid-19-drug-remdesivir-1.jpg\",\"contentUrl\":\"https:\/\/chemicalsafety.com\/wp-content\/uploads\/2020\/05\/gileads-covid-19-drug-remdesivir-1.jpg\",\"width\":750,\"height\":400,\"caption\":\"U.S. emergency approval broadens use of Gilead\u2019s COVID-19 drug remdesivir\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/chemicalsafety.com\/es\/#website\",\"url\":\"https:\/\/chemicalsafety.com\/es\/\",\"name\":\"ChemicalSafety\",\"description\":\"EH&amp;S Software\",\"publisher\":{\"@id\":\"https:\/\/chemicalsafety.com\/es\/#organization\"},\"alternateName\":\"Chemical Safety Software\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/chemicalsafety.com\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/chemicalsafety.com\/es\/#organization\",\"name\":\"ChemicalSafety\",\"alternateName\":\"Chemical Safety Software\",\"url\":\"https:\/\/chemicalsafety.com\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/chemicalsafety.com\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/chemicalsafety.com\/wp-content\/uploads\/2018\/01\/logo4.png\",\"contentUrl\":\"https:\/\/chemicalsafety.com\/wp-content\/uploads\/2018\/01\/logo4.png\",\"width\":100,\"height\":100,\"caption\":\"ChemicalSafety\"},\"image\":{\"@id\":\"https:\/\/chemicalsafety.com\/es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Chemical-Safety-Software-1391503304442241\/\",\"https:\/\/x.com\/chemsafeems\",\"https:\/\/www.linkedin.com\/company\/chemical-safety-software\/\",\"https:\/\/www.youtube.com\/channel\/UC3i_ZkwvVM2HnmO65fzFu4A\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/chemicalsafety.com\/es\/#\/schema\/person\/9a6af7129d32d51cd09d6bbfbcb03336\",\"name\":\"Chemical Safety Software\",\"sameAs\":[\"http:\/\/chemicaldafety.com\"],\"url\":\"https:\/\/chemicalsafety.com\/es\/author\/iokastik\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"La aprobaci\u00f3n de emergencia de EE. UU. Ampl\u00eda el uso del medicamento COVID-19 remdesivir de Gilead","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/chemicalsafety.com\/es\/la-aprobacion-de-emergencia-de-ee-uu-amplia-el-uso-del-medicamento-covid-19-remdesivir-de-gilead\/","og_locale":"es_ES","og_type":"article","og_title":"La aprobaci\u00f3n de emergencia de EE. UU. Ampl\u00eda el uso del medicamento COVID-19 remdesivir de Gilead","og_description":"Durante estos tiempos dif\u00edciles, las buenas noticias siempre son bienvenidas y deben compartirse. Nos sentimos honrados y orgullosos de anunciar que Gilead Sciences, uno de los clientes m\u00e1s antiguos e importantes de Chemical Safety Software, ha recibido la aprobaci\u00f3n de la Administraci\u00f3n de Drogas y Alimentos de los EE. UU. (FDA) para su tratamiento experimental [&hellip;]","og_url":"https:\/\/chemicalsafety.com\/es\/la-aprobacion-de-emergencia-de-ee-uu-amplia-el-uso-del-medicamento-covid-19-remdesivir-de-gilead\/","og_site_name":"ChemicalSafety","article_publisher":"https:\/\/www.facebook.com\/Chemical-Safety-Software-1391503304442241\/","article_published_time":"2021-01-07T21:20:26+00:00","article_modified_time":"2025-10-01T08:09:13+00:00","og_image":[{"width":750,"height":400,"url":"https:\/\/chemicalsafety.com\/wp-content\/uploads\/2020\/05\/gileads-covid-19-drug-remdesivir-1.jpg","type":"image\/jpeg"}],"author":"Chemical Safety Software","twitter_card":"summary_large_image","twitter_creator":"@chemsafeems","twitter_site":"@chemsafeems","twitter_misc":{"Escrito por":"Chemical Safety Software","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/chemicalsafety.com\/es\/la-aprobacion-de-emergencia-de-ee-uu-amplia-el-uso-del-medicamento-covid-19-remdesivir-de-gilead\/#article","isPartOf":{"@id":"https:\/\/chemicalsafety.com\/es\/la-aprobacion-de-emergencia-de-ee-uu-amplia-el-uso-del-medicamento-covid-19-remdesivir-de-gilead\/"},"author":{"name":"Chemical Safety Software","@id":"https:\/\/chemicalsafety.com\/es\/#\/schema\/person\/9a6af7129d32d51cd09d6bbfbcb03336"},"headline":"La aprobaci\u00f3n de emergencia de EE. UU. Ampl\u00eda el uso del medicamento COVID-19 remdesivir de Gilead","datePublished":"2021-01-07T21:20:26+00:00","dateModified":"2025-10-01T08:09:13+00:00","mainEntityOfPage":{"@id":"https:\/\/chemicalsafety.com\/es\/la-aprobacion-de-emergencia-de-ee-uu-amplia-el-uso-del-medicamento-covid-19-remdesivir-de-gilead\/"},"wordCount":252,"publisher":{"@id":"https:\/\/chemicalsafety.com\/es\/#organization"},"image":{"@id":"https:\/\/chemicalsafety.com\/es\/la-aprobacion-de-emergencia-de-ee-uu-amplia-el-uso-del-medicamento-covid-19-remdesivir-de-gilead\/#primaryimage"},"thumbnailUrl":"https:\/\/chemicalsafety.com\/wp-content\/uploads\/2020\/05\/gileads-covid-19-drug-remdesivir-1.jpg","articleSection":["Sin categorizar"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/chemicalsafety.com\/es\/la-aprobacion-de-emergencia-de-ee-uu-amplia-el-uso-del-medicamento-covid-19-remdesivir-de-gilead\/","url":"https:\/\/chemicalsafety.com\/es\/la-aprobacion-de-emergencia-de-ee-uu-amplia-el-uso-del-medicamento-covid-19-remdesivir-de-gilead\/","name":"La aprobaci\u00f3n de emergencia de EE. UU. Ampl\u00eda el uso del medicamento COVID-19 remdesivir de Gilead","isPartOf":{"@id":"https:\/\/chemicalsafety.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/chemicalsafety.com\/es\/la-aprobacion-de-emergencia-de-ee-uu-amplia-el-uso-del-medicamento-covid-19-remdesivir-de-gilead\/#primaryimage"},"image":{"@id":"https:\/\/chemicalsafety.com\/es\/la-aprobacion-de-emergencia-de-ee-uu-amplia-el-uso-del-medicamento-covid-19-remdesivir-de-gilead\/#primaryimage"},"thumbnailUrl":"https:\/\/chemicalsafety.com\/wp-content\/uploads\/2020\/05\/gileads-covid-19-drug-remdesivir-1.jpg","datePublished":"2021-01-07T21:20:26+00:00","dateModified":"2025-10-01T08:09:13+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/chemicalsafety.com\/es\/la-aprobacion-de-emergencia-de-ee-uu-amplia-el-uso-del-medicamento-covid-19-remdesivir-de-gilead\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/chemicalsafety.com\/es\/la-aprobacion-de-emergencia-de-ee-uu-amplia-el-uso-del-medicamento-covid-19-remdesivir-de-gilead\/#primaryimage","url":"https:\/\/chemicalsafety.com\/wp-content\/uploads\/2020\/05\/gileads-covid-19-drug-remdesivir-1.jpg","contentUrl":"https:\/\/chemicalsafety.com\/wp-content\/uploads\/2020\/05\/gileads-covid-19-drug-remdesivir-1.jpg","width":750,"height":400,"caption":"U.S. emergency approval broadens use of Gilead\u2019s COVID-19 drug remdesivir"},{"@type":"WebSite","@id":"https:\/\/chemicalsafety.com\/es\/#website","url":"https:\/\/chemicalsafety.com\/es\/","name":"ChemicalSafety","description":"EH&amp;S Software","publisher":{"@id":"https:\/\/chemicalsafety.com\/es\/#organization"},"alternateName":"Chemical Safety Software","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/chemicalsafety.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/chemicalsafety.com\/es\/#organization","name":"ChemicalSafety","alternateName":"Chemical Safety Software","url":"https:\/\/chemicalsafety.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/chemicalsafety.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/chemicalsafety.com\/wp-content\/uploads\/2018\/01\/logo4.png","contentUrl":"https:\/\/chemicalsafety.com\/wp-content\/uploads\/2018\/01\/logo4.png","width":100,"height":100,"caption":"ChemicalSafety"},"image":{"@id":"https:\/\/chemicalsafety.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Chemical-Safety-Software-1391503304442241\/","https:\/\/x.com\/chemsafeems","https:\/\/www.linkedin.com\/company\/chemical-safety-software\/","https:\/\/www.youtube.com\/channel\/UC3i_ZkwvVM2HnmO65fzFu4A"]},{"@type":"Person","@id":"https:\/\/chemicalsafety.com\/es\/#\/schema\/person\/9a6af7129d32d51cd09d6bbfbcb03336","name":"Chemical Safety Software","sameAs":["http:\/\/chemicaldafety.com"],"url":"https:\/\/chemicalsafety.com\/es\/author\/iokastik\/"}]}},"_links":{"self":[{"href":"https:\/\/chemicalsafety.com\/es\/wp-json\/wp\/v2\/posts\/71077","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/chemicalsafety.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/chemicalsafety.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/chemicalsafety.com\/es\/wp-json\/wp\/v2\/users\/3590"}],"replies":[{"embeddable":true,"href":"https:\/\/chemicalsafety.com\/es\/wp-json\/wp\/v2\/comments?post=71077"}],"version-history":[{"count":0,"href":"https:\/\/chemicalsafety.com\/es\/wp-json\/wp\/v2\/posts\/71077\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/chemicalsafety.com\/es\/wp-json\/wp\/v2\/media\/89595"}],"wp:attachment":[{"href":"https:\/\/chemicalsafety.com\/es\/wp-json\/wp\/v2\/media?parent=71077"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/chemicalsafety.com\/es\/wp-json\/wp\/v2\/categories?post=71077"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/chemicalsafety.com\/es\/wp-json\/wp\/v2\/tags?post=71077"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}